Policy liaison initiative: Relevant and accessible evidence from The Cochrane Library
Logo for Australasian Cochrane Centre
Arthritis & Musculoskeletal Asthma Cancer Cardiovascular Diabetes Injury Mental Health

Policy liaison home
Review summaries
Cochrane & Mental Health
Topics & Reviews
Review summaries
Australia's contribution 
Impact on health care
Research priorities

Other policy relevant Cochrane work 
Effective Practice and Organisation of Care
Consumers and Communication 
Evidence-Based Policy Network 
About the EBPN
Events
Bulletin - latest news

Helpdesk for EBPN
Resources 
Cochrane Library logon
NICS Cochrane Library guide
Australasian Cochrane Centre
National Health Priority Areas website

Mental health reviews by topic

Issue 7, 2010 of The Cochrane Library included 2 reviews and 5 protocols on mental health.  Topics and reviews on schizophrenia, depression, anxiety and neurosis are presented on this site. A full list of topics and reviews is given below.

Click on the title to view the full review or protocol

Log on to The Cochrane Library to read protocols and full reviews. (click here for search tip)

[R] Cochrane review

[P] Protocol for Cochrane review
[S] Summary of Cochrane review available

Quick links to depression, anxiety and neurosis topics:

Topic Reviews and Protocols 
Click on title to view review or protocol
Mood disorders Due to medical conditions
  1. Aripiprazole for psychosis-induced aggression or agitation  [P]
  2. Interventions for psychotic symptoms concomitant with epilepsy  [R]
  3. Intravenous immunoglobulins for epilepsy  [P]
  4. Lamotrigine add-on for drug-resistant partial epilepsy  [R]
Due to substance-induced mood disorder
  1. No reviews currently available for this topic
Mood disorder not otherwise specified
  1. Advance treatment directives for people with severe mental illness  [R]
  2. Antiglucocorticoid treatments for mood disorders [R]
  3. Chlorpromazine for psychosis induced aggression or agitation  [P]
  4. Exercise in prevention and treatment of anxiety and depression among children and young people  [R]
  5. Exercise to improve self-esteem in children and young people  [R]  [S] 
  6. Haloperidol plus promethazine for psychosis-induced aggression  [P]
  7. Intensive Case Management for severe mental illness  [P]
  8. Interventions for mood and anxiety disorders, and self harm in young offenders  [P]
  9. Lithium for maintenance treatment of mood disorders  [R]
  10. Prevention of suicide and suicidal behaviour in adolescents  [P]
  11. Psychosocial interventions for the secondary prevention of mental health problems in people who have sustained a traumatic physical injury  [P]
  12. Return to work interventions for adjustment disorders  [P]
  13. Shared decision making interventions for people with mental health conditions  [R]
  14. Short-term psychodynamic psychotherapies for common mental disorders  [R]  [S]

Back to Top

Depressive disorders Major depressive disorder
  1. Antidepressants and benzodiazepines for major depression  [R]
  2. Low dosage tricyclic antidepressants for depression  [R]  [S]
  3. Second-generation antipsychotic drugs for major depressive disorder  [P]
Dysthymic disorder
  1. Drugs versus placebo for dysthymia  [R]
  2. Pharmacotherapy for dysthymia  [R]  [S]
Depressive disorder
  1. Active placebos versus antidepressants for depression  [R]  [S]
  2. Acupuncture for depression  [R]
  3. Alprazolam for depression  [P]
  4. Amitriptyline for depression  [R]  [S]
  5. Antidepressant prevention of postnatal depression  [R]
  6. Antidepressants for anorexia nervosa  [R]  [S]  
  7. Antidepressants for depressed elderly  [R]  [S]
  8. Antidepressants for depression in adults with HIV infection  [P]
  9. Antidepressants for depression in physically ill people  [R]
  10. Antidepressants in the treatment of depression in dementia  [R]  [S] 
  11. Antidepressants versus placebo for depression in primary care  [R]
  12. Antidepressants versus placebo for the depressed elderly  [R]
  13. Antidepressant treatment for post-natal depression  [R]  [S]
  14. Electroconvulsive therapy for the depressed elderly  [R]  [S]
  15. Escitalopram versus other antidepressive agents for depression  [R]
  16. Exercise for depression  [R]
  17. Exercise for older depressed people  [P]
  18. Fluvoxamine versus other anti-depressive agents for depression  [R]
  19. Fluoxetine versus other types of pharmacotherapy for depression  [R]  [S]
  20. Folate for depressive disorders  [R]  [S]
  21. Inositol for depressive disorders  [R] [S]
  22. Interventions for helping people recognise early signs of recurrence in depression  [P]
  23. Interventions for preventing depression after stroke  [R]  [S]
  24. Interventions for preventing relapse and recurrence after the first episode of a depressive disorder in young people  [P]
  25. Interventions for treating depression after stroke  [R]
  26. Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression  [R]
  27. Interventions to improve occupational health in depressed people  [R]
  28. Light therapy for non-seasonal depression  [R]  [S]
  29. Lithium versus antidepressants in the long-term treatment of unipolar affective disorder  [R]  [S]
  30. Marital therapy for depression  [R]  [S]
  31. Milnacipran versus other antidepressive agents for depression  [R]
  32. Music therapy for depression  [R]
  33. Neurosurgery for obsessive-compulsive disorder, other anxiety disorders and depressive disorders  [P]
  34. Pharmacological treatment of depression in patients with a primary brain tumour  [R]
  35. Pharmacological treatment for psychotic depression  [R]  [S]
  36. Pharmacologic treatment of depression in multiple sclerosis  [P]
  37. Psychological and/or educational interventions for the prevention of depression in children and adolescents  [R]  [S]
  38. Psychological and pharmacological interventions for depression in patients with coronary artery disease  [P]
  39. Psychological and pharmacological interventions for depression in patients with diabetes mellitus  [P]
  40. Psychological interventions for depression in adolescent and adult congenital heart disease  [R]
  41. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents  [P]
  42. Psychosocial and psychological interventions for preventing postpartum depression  [R]  [S]
  43. Psychosocial interventions by general practitioners  [R]  [S]
  44. Psychosocial interventions for prevention of depression in older people  [P]
  45. Psychosocial interventions for prevention of psychological disorders in law enforcement officers  [R]
  46. Psychostimulants for depression  [R]
  47. Psychotherapeutic treatments for older depressed people  [R]
  48. Psychotherapy for depression among incurable cancer patients  [R]
  49. Psychotherapy for depression in children and adolescents  [P]
  50. Reboxetine versus other antidepressive agents for depression  [P]
  51. Relaxation for depression  [R]
  52. Screening and case finding instruments for depression  [R]  [S]
  53. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents  [R] [s]
  54. Sertraline versus other antidepressive agents for depression  [R]
  55. St John's wort for major depression  [R]  [S]
  56. Tai Chi for depression  [P]
  57. Transcranial magnetic stimulation for treating depression  [R]
  58. Tricyclic drugs for depression in children and adolescents  [R]
  59. Tryptophan and 5-Hydroxytryptophan for depression  [R]

Back to Top

Bipolar disorder Bipolar I and II disorder
  1. Aripiprazole alone or in combination for acute mania  [P]
  2. Family interventions for bipolar disorde[R]
  3. Haloperidol alone or in combination for acute mania  [R]
  4. Interventions for helping people recognise early signs of recurrence in bipolar disorder  [R]
  5. Lithium for acute mania  [P]
  6. Olanzapine alone or in combination for acute mana  [R] [S]
  7. Olanzapine in long-term treatment for bipolar disorder  [R]
  8. Omega-3 fatty acids for bipolar disorder  [R]
  9. Oxcarbazepine in the maintenance treatment of bipolar disorder  [R]
  10. Oxcarbazepine in the treatment of acute affective episodes in bipolar disorder: efficacy and acceptability  [P]
  11. Risperidone alone or in combination for acute mania  [R]
  12. Risperidone in long-term treatment for bipolar disorder  [R]  [S]
  13. Tiagabine in the maintenance treatment of bipolar disorder[R]  [S]
  14. Tiagabane in the treatment of acute affective episodes in bipolar disorder  [R]  [S]
  15. Topiramate for acute affective episodes in bipolar disorder  [R]  [S]
  16. Valproate for acute mood episodes in bipolar disorder  [R]  [S]
  17. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder  [R]
  18. Ziprasidone alone or in combination for acute mania  [P]
Cyclothymic disorder
  1. No reviews currently available for this topic

Back to Top

Anxiety disorders Panic disorder without agoraphobia
  1. Cognitive behavioural therapy for anxiety disorders in later life  [P]
  2. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia  [R]
  3. Combined psychotherapy plus benzodiazepines for panic disorder  [R]

Panic disorder with agoraphobia

  1. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia  [R]
  2. Combined psychotherapy plus benzodiazepines for panic disorder  [R]

Agoraphobia without a history of panic disorder

  1. No reviews currently available for this topic

Specific phobia

  1. No reviews currently available for this topic

Social phobia

  1. Pharmacotherapy for social anxiety disorder  [R]

Obsessive compulsive disorder

  1. Behavioural and cognitive-behavioural therapy for obsessive-compulsive disorder in children and adolescents  [R]
  2. Neurosurgery for obsessive-compulsive disorder, other anxiety disorders and depressive disorders  [P]
  3. Pharmacological interventions for obsessive-compulsive personality disorder  [P]
  4. Psychological interventions for obsessive-compulsive personality disorder  [P]
  5. Psychological therapies versus pharmacotherapy for obsessive compulsive disorder  [P]
  6. Second-generation antipsychotic drugs for obsessive compulsive disorder  [P]
  7. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)  [R]
  8. Transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder  [R]  [S]

Traumatic stress disorder

  1. Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD)  [R]
  2. Early psychological interventions to treat acute traumatic stress symptoms  [R]
  3. Multiple session early psychological interventions for the prevention of post-traumatic stress disorder  [R]
  4. Pharmacotherapy for post traumatic stress disorder (PTSD)  [R]  [S]
  5. Pharmacotherapy for prevention of post-traumatic stress disorder  [P]
  6. Psychological debriefing for preventing post traumatic stress disorder (PTSD)  [R]
  7. Psychological therapies for the prevention and treatment of post-traumatic stress disorder in children and adolescents  [P]
  8. Psychological treatment of post-traumatic stress disorder (PTSD)  [R]  [S]
  9. Sports and games for post-traumatic stress disorder (PTSD)  [R]
  10. Transcranial magnetic stimulation for post-traumatic stress disorder  [P]

Acute stress disorder

  1. No reviews currently available for this topic

Generalised anxiety

  1. Antidepressants for generalized anxiety disorde[R]  [S]
  2. Azapirones for generalized anxiety disorder  [R]
  3. Hydroxyzine for generalised anxiety disorder  [P]
  4. Psychological therapies for generalised anxiety disorder  [R]

Anxiety disorder due to general medical condition

  1. Drug therapy for anxiety in palliative care  [R]  [S] 
  2. Pharmacological interventions for the treatment of anxiety and panic in chronic obstructive pulmonary disease  [P]
  3. Premedication for anxiety in adult day surgery  [R]

Substance induced anxiety disorder

  1. No reviews currently available for this topic

Anxiety disorder not otherwise specified

  1. Augmentation of psychotherapy with d-cycloserine for anxiety disorders  [P]
  2. Benzodiazepines for delirium  [P]

  3. Cognitive-behavioural interventions for children who have been sexually abused  [R]  [S]
  4. Duloxetine for Generalized Anxiety Disorder (GAD)  [P]
  5. Kava extract versus placebo for treating anxiety  [R]  [S]
  6. Massage and touch for dementia  [R]  [S]
  7. Meditation therapy for anxiety disorders  [R]
  8. Memantine for dementia  [R]  [S]
  9. Neurosurgery for obsessive-compulsive disorder, other anxiety disorders and depressive disorders  [P]
  10. Newer anticonvulsants in the treatment of anxiety disorders  [P]

  11. Paraprofessionals for depressive and anxiety disorders  [R]  [S]
  12. Passiflora for anxiety disorder  [R]
  13. Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders  [R]

  14. Pharmacotherapy for anxiety disorders in children and adolescents  [R]
  15. Pharmacotherapy for anxiety disorders in later life  [P]

  16. Psychosocial interventions for prevention of psychological disorders in law enforcement officers  [P]
  17. Screening and case finding instruments for depression  [R]
  18. Second-generation antipsychotic drugs for anxiety disorders  [P]

  19. Therapeutic touch for anxiety disorders  [R]

  20. Valerian for anxiety disorder  [R]  [S]

Back to Top

Schizophrenia   Care package/Setting of Care
  1. Community mental health teams (CMHTs) for people with severe mental illnesses and disordered personality  [R]
  2. Compulsory community and involuntary outpatient treatment for people with severe mental disorders  [R]
  3. Containment strategies for people with serious mental illness  [R]  [S]

  4. Crisis intervention for people with severe mental illnesses  [R]

  5. Day hospital versus admission for acute psychiatric disorders  [R]
  6. Day hospital versus outpatient care for people with schizophrenia  [R]
  7. Length of hospitalisation for people with severe mental illness  [R]
  8. Monetary incentives for schizophrenia  [R]

  9. Open general medical wards versus specialist psychiatric units for acute psychoses   [R]
  10. Outcome measures and needs assessment tools for schizophrenia and related disorders  [R]  [S]
  11. Psychosocial interventions for people with both severe mental illness and substance misuse  [R]
  12. Rehabilitation programmes for schizophrenia  [P]

  13. Supported housing for people with severe mental disorders  [R]
  14. Treatment delivery using information and communication technology for people with schizophrenia  [P]

  15. Twenty-four hour care for schizophrenia  [R]

Drugs

  1. Beta-blocker supplementation of standard drug treatment for schizophrenia  [R] 

Amino acids, enzymes, oils and nutritional agents

  1. Glutamatergic drugs for schizophrenia  [R]  [S]
  2. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia  [R]
  3. Polyunsaturated fatty acid supplementation for schizophrenia  [R]  [S]
  4. Vitamin E for neuroleptic-induced tardive dyskinesia  [R]

Anaesthesia-related agents / muscle relaxants

  1. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia  [R]

Anti-convulsants / convulsants

  1. Carbamazepine for schizophrenia  [R]
  2. Lamotrigine for schizophrenia  [R]  [S]
  3. Valproate for schizophrenia  [R]  [S]

Anti-depressants

  1. Antidepressants for people with both schizophrenia and depression  [R]
  2. Antidepressants for the negative symptoms of schizophrenia  [R]  [S]
  3. Lithium for schizophrenia  [R]  [S]
  4. Maintenance treatment with antipsychotic drugs for schizophrenia  [P]
  5. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia  [R]

Anti-glucocorticoids

  1. Antiglucocorticoid and related treatments for psychosis  [P]

Anti-movement disorders

  1. Anticholinergic medication for neuroleptic-induced tardive dyskinesia  [R]
  2. Anticholinergics for neuroleptic-induced acute akathisia  [R]  [S]
  3. Benzodiazepines for neuroleptic-induced tardive dyskinesia  [R]  [S]
  4. Calcium channel blockers for neuroleptic-induced tardive dyskinesia  [R]  [S]
  5. Cholinergic medication for neuroleptic-induced tardive dyskinesia  [R]
  6. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia  [R]
  7. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia  [R]

Anti-psychotics

  1. Acetylcholinesterase inhibitors for schizophrenia  [P]
  2. Amisulpride for schizophrenia  [R]
  3. Amisulpride versus other atypical antipsychotics for schizophrenia  [R]
  4. Amphetamines for schizophrenia  [R]  [S] 
  5. Antipsychotic medication for early episode schizophrenia  [P]
  6. Antipsychotic medication versus placebo for people with both schizophrenia and learning disability  [R]  [S]
  7. Antipsychotic drug treatment for elderly people with late-onset schizophrenia  [R]  [S]
  8. Antipsychotic medication for elderly people with schizophrenia  [R]  [S]
  9. Aripiprazole for schizophrenia  [R]  [S]
  10. Aripiprazole versus other atypical antipsychotics for schizophrenia  [R]
  11. Aripiprazole versus typical antipsychotic drugs for schizophrenia  [R]
  12. 'As required' medication regimens for seriously mentally ill people in hospital  [R]
  13. Atypical antipsychotics for people with both schizophrenia and depression  [R]
  14. Benperidol for schizophrenia  [R]  [S]
  15. Chlorpromazine dose for people with schizophrenia  [R]
  16. Chlorpromazine versus placebo for schizophrenia  [R]  [S]
  17. Clotiapine for acute psychotic illnesses  [R]
  18. Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia  [R]
  19. Clozapine versus typical neuroleptic medication for schizophrenia  [R]
  20. Depot bromperidol decanoate for schizophrenia  [R]  [S]
  21. Depot flupenthixol decanoate for schizophrenia or other similar psychotic disorders  [R]
  22. Depot fluphenazine decanoate and enanthate for schizophrenia  [R]  [S]
  23. Depot fluspirilene for schizophrenia  [R]
  24. Depot risperidone for schizophrenia  [R]  [S]
  25. Depot perphenazine decanoate and enanthate for schizophrenia  [R]  [S]
  26. Depot pipotiazine palmitate and undecylenate for schizophrenia  [R]  [S]
  27. Droperidol for acute psychosis  [R]
  28. Haloperidol dose for the acute phase of schizophrenia  [R]
  29. Haloperidol versus placebo for schizophrenia  [R]  [S]
  30. Haloperidol versus chlorpromazine for schizophrenia  [R]
  31. Intermittent drug techniques for schizophrenia  [P]
  32. Levomepromazine for schizophrenia  [P]
  33. Loxapine for schizophrenia  [R]
  34. Molindone for schizophrenia and severe mental illness  [R]
  35. Newer atypical antipsychotic medication versus clozapine for schizophrenia  [R]
  36. New generation antipsychotics for first episode schizophrenia  [R]  [S]
  37. Olanzapine for schizophrenia  [R]  [S]
  38. Olanzapine depot for schizophrenia  [P]
  39. Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses  [R]
  40. Olanzapine versus other atypical antipsychotics for schizophrenia  [R]
  41. Oral paliperidone for schizophrenia  [R]
  42. Pericyazine for schizophrenia  [P]
  43. Pharmacological interventions for clozapine-induced hypersalivation  [R]
  44. Pharmacological treatments for psychosis-related polydipsia  [R]  [S]
  45. Paliperidone palmitate for schizophrenia  [P]
  46. Penfluridol for schizophrenia  [R]  [S]
  47. Pimozide for schizophrenia or related psychoses  [R]
  48. Perazine for schizophrenia  [R]  [S]
  49. Perphenazine for schizophrenia  [R]  [S]
  50. Quetiapine for schizophrenia  [R]  [S]
  51. Quetiapine versus other atypical antipsychotics for schizophrenia  [R]
  52. Quetiapine versus typical antipsychotic medications for schizophrenia  [P]
  53. Risperidone dose for schizophrenia  [R]
  54. Risperidone versus olanzapine for schizophrenia  [R]  [S]
  55. Risperidone versus placebo for schizophrenia  [R]
  56. Risperidone versus other atypical antipsychotic medication for schizophrenia  [R]
  57. Risperidone versus typical antipsychotic medication for schizophrenia  [R]  [S]
  58. Sertindole for schizophrenia  [R]  [S]
  59. Sulpiride for schizophrenia  [R]
  60. Thioridazine for schizophrenia  [R]
  61. Trifluoperazine for schizophrenia  [R]  [S]
  62. Sertindole versus other atypical antipsychotics for schizophrenia  [R]
  63. Sulpiride versus placebo for schizophrenia  [R]
  64. Sulpiride augmentation for schizophrenia  [R]
  65. Sulpiride versus other antipsychotics for schizophrenia  [P]
  66. Ziprasidone for schizophrenia and severe mental illness  [R]
  67. Ziprasidone versus other atypical antipsychotics for schizophrenia  [R]
  68. Zotepine for schizophrenia  [R]  [S]
  69. Zotepine versus other atypical antipsychotics for schizophrenia  [R]
  70. Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses  [R]  [S]
  71. Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses  [R]
  72. Zuclopenthixol dihydrochloride for schizophrenia  [R]  [S]

Anxiolytics / hypnotics

  1. Benzodiazepines for psychosis-induced aggression or agitation  [R]
  2. Benzodiazepines for neuroleptic-induced acute akathisia  [R]
  3. Benzodiazepines for neuroleptic-induced tardive dyskinesia  [R]  [S]
  4. Benzodiazepines for schizophrenia  [R]

Central nervous system stimulants / depressants

  1. Cannabis and schizophrenia  [R]
  2. Nicotine for schizophrenia  [R]  [S]

Hormones

  1. Estrogen for schizophrenia  [R]  [S]
  2. Testosterone for schizophrenia  [R]

Parasympathomimetic / Sympathomimetic agents

  1. Non-neuroleptic catecholaminergic drugs for neuroleptic-induced tardive dyskinesia  [R]

Physical treatments other than drugs

  1. Acupuncture for schizophrenia  [R]
  2. Ayurvedic medicine for schizophrenia  [R]
  3. Chinese herbal medicine for schizophrenia  [R]  [S]
  4. Electroconvulsive therapy for schizophrenia  [R]  [S]
  5. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia  [R]

Therapy

  1. Art therapy for schizophrenia or schizophrenia-like illnesses  [R]  [S]
  2. Cognitive behaviour therapy for schizophrenia  [R]  [S]
  3. Cognitive behaviour therapy versus specific pharmacological treatments for schizophrenia  [P]
  4. Cognitive behaviour therapy versus standard care for schizophrenia  [P]
  5. Cognitive rehabilitation for people with schizophrenia and related conditions  [R]
  6. Compliance therapy for schizophrenia  [R]  [S]
  7. Dance therapy for schizophrenia  [R]
  8. Distraction techniques for schizophrenia  [R]  [S]
  9. Drama therapy for schizophrenia or schizophrenia-like illnesses  [R]
  10. Early intervention for psychosis  [R]  [S]
  11. Educational games for mental health professionals  [R]
  12. Exercise therapy for schizophrenia  [R]
  13. Family intervention for schizophrenia  [R]  [S]
  14. Hypnosis for schizophrenia  [R]  [S]
  15. Individual psychodynamic psychotherapy and psychoanalysis for schizophrenia and severe mental illness  [R]
  16. Life skills programmes for chronic mental illnesses  [R]
  17. Morita therapy for schizophrenia  [R]
  18. Music therapy for schizophrenia or schizophrenia-like illnesses  [R]  [S]
  19. Problem solving skills for schizophrenia  [R]
  20. Psychoeducation for schizophrenia  [R]
  21. Supportive therapy for schizophrenia  [R]
  22. Token economy for schizophrenia  [R]
  23. Vocational rehabilitation for people with severe mental illness  [R]

Back to Top

Clinically significant problems associated with these disorders
  1. Acupuncture for insomnia  [R]
  2. Alternatives to inpatient mental health care for children and young people  [R]
  3. Benzodiazepines for catatonia in people with schizophrenia and other serious mental illnesses  [R]
  4. Carbohydrates for improving the cognitive performance of independent-living older adults with normal cognition or mild cognitive impairment  [P]
  5. Cognitive-behavioral treatment for antisocial behavior in youth in residential treatment  [R] 
  6. Effectiveness and cost effectiveness of counselling in primary care  [R]
  7. Interventions for smoking cessation and reduction in individuals with schizophrenia  [R]
  8. Life skills programmes for chronic mental illnesses  [R]
  9. Pharmacotherapy and psychotherapy for body dysmorphic disorder  [P]
  10. Physical activity for improving cognition in older people with mild cognitive impairment  [P]
  11. Physical health care monitoring for people with serious mental illness  [P]
  12. Preventing occupational stress in healthcare workers  [R]
  13. Problem solving treatment (PST) for emotional problems in primary care  [P]
  14. Prompts to encourage appointment attendance for people with serious mental illness  [R]
  15. Psychosocial and pharmacological treatments for deliberate self harm  [R]
  16. Psychosocial interventions by general practitioners  [R]  [S]
  17. Psychosocial interventions for conversion disorder  [R]
  18. Psychosocial interventions for people with both severe mental illness and substance misuse  [R]
  19. Reiki treatment for psychological symptoms  [P]
  20. Strategies for managing sexual dysfunction induced by antidepressant medication  [R]  [S]
  21. Subjective barriers to prevent wandering of cognitively impaired people  [R]
  22. Supported employment for adults with severe mental illness  [P]
  23. Supported housing for people with severe mental disorders  [R]  [S] 

Back to Top

Last updated 19 Jul 2010

This website is produced and maintained  by the Australasian Cochrane Centre for members of the Evidence-Based Policy Network, Australian Government Department of Health and Ageing.